Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)

Obesity and Gastrointestinal Hormones-Dual Effect of Angiotensin II Receptor Blockade and a Partial Agonist of PPAR-γ

(2011) Hironori Nakagami et al.   Current Vascular Pharmacology

Ethnic differences in body composition and the associated metabolic profile: A comparative study between Asians and Caucasians

(2010) S.N. Wulan et al.   MATURITAS

Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome

(2010) Emily J. Gallagher et al.   MOUNT SINAI JOURNAL OF MEDICINE

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients

(2009) R. Fogari et al.   HORMONE AND METABOLIC RESEARCH

Next generation multifunctional angiotensin receptor blockers

(2009) Theodore W Kurtz et al.   HYPERTENSION RESEARCH

Insulin resistance and blood pressure

(2008) Sonya Addison et al.   CURRENT HYPERTENSION REPORTS

Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: A systematic review and meta-analysis focusing on fasting serum insulin

(2008) Masakazu Takeuchi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Ethnic diversity in Type 2 diabetes

(2008) T. M. E. Davis   DIABETIC MEDICINE

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks

(2008) Toshio Ogihara et al.   HYPERTENSION

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy

(2008) M. John Chapman et al.   PHARMACOLOGY & THERAPEUTICS